Abstract #1059
Metabolomic Imaging for Human Prostate Cancer Detection using MR Spectroscopy at 7-T
Romy Langhammer 1,2 , Leo L. Cheng 1 , Johannes Nowak 3 , Shulin Wu 1 , W. Scott McDougal 1 , Chin-Lee Wu 1 , and Eva M. Ratai 1
1
Massachusetts General Hospital, Harvard
Medical School, Boston, Massachusetts, United States,
2
Institute
of Radiolgy, Department for Neuroradiology, University
Hospital Wuerzburg, Wuerzburg, Bavaria, Germany,
3
Institute
of Radiology, Department for Neuroradiology, University
Hospital Wuerzburg, Wuerzburg, Bavaria, Germany
The project aims to develop a non-invasive diagnostic
test for prostate cancer. Metabolomic imaging maps of
thirty whole prostates were created and analyzed, using
magnetic resonance spectroscopy (MRS) at 7T. To test the
functionality and reliability of this system, the
outcome has been compared with the histopathology
findings. In 61% of the samples, MRS detected cancer
lesions in the same locations as were identified in the
histopathology analysis; the histological regions that
were not detected had significantly lower tumor volumes.
Furthermore, a "Malignancy Index" can significantly
differentiate between cancerous and benign MRS
suspicious regions.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
